Open AccessConsensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis
Author(s) -
Michael Kaliner,
James N. Baraniuk,
Michael S. Benninger,
Jonathan A. Bernstein,
Phil Lieberman,
Eli O. Meltzer,
Robert M. Naclerio,
Russell A. Settipane,
Judith R. Farrar
Publication year - 2009
Publication title -
world allergy organization journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.041
H-Index - 37
ISSN - 1939-4551
DOI - 10.1097/wox.0b013e3181b2ff8a
Subject(s) - nonallergic rhinitis , medicine , vasomotor rhinitis , rhinorrhea , clinical trial , nasal congestion , inclusion and exclusion criteria , vasomotor , disease , intensive care medicine , alternative medicine , dermatology , asthma , pathology , immunology , nose , surgery
"Nonallergic rhinopathy" was defined by consensus at a Roundtable conference in December 2008 as "a chronic nasal condition with symptoms that may be perennial, persistent, intermittent or seasonal and/or elicited by recognized triggers." The definition includes a well-recognized set of clinical exposures that lead to the symptoms, predominantly congestion, rhinorrhea, and postnasal drip. These clinical characteristics help to identify patients for participation in clinical trials examining the efficacy of treatments for this important disease. The next step is to establish inclusion and exclusion criteria that will provide a framework for the clinical trials. Agreement on study criteria was obtained at the consensus conference by discussion, counterpoint, and compromise.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom